Benzinga | Sep 22, 2021 06:12AM EDT

WBB Securities Upgrades Cidara Therapeutics to Strong Buy

WBB Securities analyst Steve Brozak upgrades Cidara Therapeutics (NASDAQ:CDTX) from Buy to Strong Buy.